LifeScience AS
Ørsta, NO· latest recorded location
LifeScience AS is named on 3 US grants and 6 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 6
- Inventors
- 3
- Granted in 2026 so far
- 1
- Most recent grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 9 documents
Recent patents
- N-acetylneuraminic acid compositions and methods of use21 Jul 2026US 12,685,741 B2
- Sialic acid compositions for the use of inhibiting and treating coronavirus infection19 Aug 2025US 12,390,481 B2
- Sialic acid compositions for the use of inhibiting and treating coronavirus infection14 Nov 2023US 11,813,271 B2
- Sialic acid compositions for the use of inhibiting and treating coronavirus infection26 Mar 2026US 2026/0083762 A1
- Sialic acid compositions for use in inhibiting and treating infections in fish20 Feb 2025US 2025/0057862 A1
- Sialic acid compositions for the use of inhibiting and treating coronavirus infection9 May 2024US 2024/0148763 A1
- Sialic acid compositions for the use of inhibiting and treating coronavirus infection27 Apr 2023US 2023/0128687 A1
- Sialic acid for use in the treatment of psoriasis15 Sep 2022US 2022/0288095 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.